Literature DB >> 14708686

Interferon-alpha for HBeAg-positive chronic hepatitis B.

Antonio Craxì1, Danilo Di Bona, Calogero Cammà.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14708686     DOI： 10.1016/s0168-8278(03)00154-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  16 in total

Review 1.  The role of interferon therapy in hepatitis B.

Authors:  W Graham E Cooksley
Journal:  MedGenMed       Date:  2004-03-18

2.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

3.  [4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

Authors:  Markus Peck-Radosavljevic; Johann Deutsch; Peter Ferenci; Ivo Graziadei; Harald Hofer; Heidemarie Holzmann; Wolf-Dietrich Huber; Herman Laferl; Andreas Maieron; Rudolf Stauber; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2010-05-04       Impact factor: 1.704

4.  Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.

Authors:  Seng Gee Lim; Zahary Krastev; Tay Meng Ng; Grigor Mechkov; Iskren Andreev Kotzev; Sing Chan; Elsa Mondou; Andrea Snow; Jeff Sorbel; Franck Rousseau
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

5.  Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey.

Authors:  Mustafa Sunbul; Hakan Leblebicioglu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

6.  Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.

Authors:  Teerha Piratvisuth; George Lau; You-Chen Chao; Rui Jin; Anuchit Chutaputti; Q-B Zhang; Tawesak Tanwandee; Peter Button; Matei Popescu
Journal:  Hepatol Int       Date:  2008-02-05       Impact factor: 6.047

7.  Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B.

Authors:  Teerha Piratvisuth
Journal:  Hepatol Int       Date:  2008-03-04       Impact factor: 6.047

Review 8.  Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.

Authors:  Xuefen Li; Xia Liu; Li Tian; Yu Chen
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

9.  Management of chronic hepatitis B: consensus guidelines.

Authors:  Morris Sherman; Stephen Shafran; Kelly Burak; Karen Doucette; Winnie Wong; Nigel Girgrah; Eric Yoshida; Eberhard Renner; Philip Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

10.  Meta-analysis: the effect of interferon on development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Authors:  Yasuhiro Miyake; Haruhiko Kobashi; Kazuhide Yamamoto
Journal:  J Gastroenterol       Date:  2009-03-25       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.